Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.570
-0.020 (-0.56%)
At close: Sep 1, 2026, 4:00 PM EDT
3.540
-0.030 (-0.84%)
After-hours: Sep 1, 2026, 7:47 PM EDT

Prime Medicine Revenue

Prime Medicine had revenue of $1.15M in the quarter ending June 30, 2026, with 3.50% growth. This brings the company's revenue in the last twelve months to $4.07M, down -17.90% year-over-year. In the year 2025, Prime Medicine had annual revenue of $4.63M with 55.28% growth.

Revenue (ttm)
$4.07M
Revenue Growth
-17.90%
P/S Ratio
155.93
Revenue / Employee
$27,897
Employees
146
Market Cap
635.12M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.63M1.65M55.28%
Dec 31, 20242.98M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CorMedix462.25M
MiMedx Group355.17M
REGENXBIO174.48M
Valneva SE163.30M
Autolus Therapeutics117.39M
Verastem87.53M
OmniAb38.46M
Altimmune31.00K
Revenue Rankings